DENTSPLY SIRONA Inc. (XRAY) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Win.
32/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 2 wins, 10 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseXRAY / S&P -8.53% / 15.20% |
LoseXRAY / S&P -0.76% / 15.00% |
LoseXRAY / S&P -41.83% / 50.40% |
| 2026-Q11/3 |
WinXRAY / S&P 1.49% / -4.33% |
LoseXRAY / S&P -1.02% / 11.30% |
LoseXRAY / S&P -30.38% / 27.70% |
| 2025-Q40/3 |
LoseXRAY / S&P -8.63% / 2.65% |
LoseXRAY / S&P -2.98% / 9.00% |
LoseXRAY / S&P -33.85% / 13.40% |
| 2025-Q31/3 |
LoseXRAY / S&P -19.04% / 8.12% |
LoseXRAY / S&P -7.08% / 4.61% |
WinXRAY / S&P 112.08% / 13.45% |
| 2025-Q21/3 |
LoseXRAY / S&P 7.37% / 10.94% |
LoseXRAY / S&P -5.78% / 4.83% |
WinXRAY / S&P 447.67% / 10.63% |
| 2025-Q11/3 |
LoseXRAY / S&P -20.47% / -4.27% |
LoseXRAY / S&P -5.61% / 4.98% |
WinXRAY / S&P 925.00% / 10.57% |
| 2024-Q41/3 |
LoseXRAY / S&P -29.27% / 2.41% |
LoseXRAY / S&P -4.34% / 5.25% |
WinXRAY / S&P 629.03% / 6.15% |
| 2024-Q32/3 |
WinXRAY / S&P 9.29% / 5.89% |
LoseXRAY / S&P -0.91% / 5.89% |
WinXRAY / S&P 104.95% / 6.11% |
| 2024-Q20/3 |
LoseXRAY / S&P -24.47% / 4.28% |
LoseXRAY / S&P -1.02% / 5.38% |
LoseXRAY / S&P -81.97% / 5.12% |
| 2024-Q10/3 |
LoseXRAY / S&P -6.28% / 10.56% |
LoseXRAY / S&P 0.23% / 5.71% |
LoseXRAY / S&P -90.89% / 5.59% |
| 2023-Q40/3 |
LoseXRAY / S&P 4.60% / 11.69% |
LoseXRAY / S&P 1.10% / 6.81% |
LoseXRAY / S&P -85.97% / 7.78% |
| 2023-Q30/3 |
LoseXRAY / S&P -14.29% / -3.27% |
LoseXRAY / S&P -2.62% / 7.52% |
LoseXRAY / S&P -73.42% / -5.03% |
| 2023-Q20/3 |
LoseXRAY / S&P 2.25% / 8.74% |
LoseXRAY / S&P -4.81% / 9.50% |
LoseXRAY / S&P -400.00% / -8.57% |
| 2023-Q11/3 |
WinXRAY / S&P 23.83% / 7.50% |
LoseXRAY / S&P -5.82% / 10.77% |
LoseXRAY / S&P -387.50% / -15.69% |
| 2022-Q41/3 |
WinXRAY / S&P 12.77% / 7.56% |
LoseXRAY / S&P -7.30% / 11.88% |
LoseXRAY / S&P -336.36% / -17.99% |
| 2022-Q30/3 |
LoseXRAY / S&P -20.32% / -4.88% |
LoseXRAY / S&P -3.92% / 13.47% |
LoseXRAY / S&P -308.79% / -1.41% |
| 2022-Q20/3 |
LoseXRAY / S&P -27.15% / -16.10% |
LoseXRAY / S&P 1.80% / 13.71% |
LoseXRAY / S&P -5.92% / 11.04% |
| 2022-Q12/3 |
LoseXRAY / S&P -11.55% / -4.60% |
WinXRAY / S&P 19.56% / 15.97% |
WinXRAY / S&P 104.88% / 42.23% |
| 2021-Q41/3 |
LoseXRAY / S&P -3.71% / 11.03% |
WinXRAY / S&P 26.71% / 15.00% |
LoseXRAY / S&P -684.37% / 96.40% |
| 2021-Q31/3 |
LoseXRAY / S&P -8.07% / 0.58% |
WinXRAY / S&P 24.79% / 10.77% |
LoseXRAY / S&P -605.56% / 69.42% |
| 2021-Q21/3 |
LoseXRAY / S&P -0.69% / 8.55% |
WinXRAY / S&P 18.14% / 6.58% |
LoseXRAY / S&P -834.78% / 51.81% |
| 2021-Q12/3 |
WinXRAY / S&P 22.07% / 6.17% |
LoseXRAY / S&P -11.77% / -1.06% |
WinXRAY / S&P 121.62% / 7.39% |
| 2020-Q41/3 |
WinXRAY / S&P 19.97% / 12.15% |
LoseXRAY / S&P -17.13% / -3.72% |
LoseXRAY / S&P -127.35% / -33.42% |
| 2020-Q30/3 |
LoseXRAY / S&P -0.52% / 8.93% |
LoseXRAY / S&P -15.23% / -2.04% |
LoseXRAY / S&P -151.43% / -27.10% |
| 2020-Q20/3 |
LoseXRAY / S&P 13.73% / 20.54% |
LoseXRAY / S&P -12.81% / -0.46% |
LoseXRAY / S&P -151.11% / -27.11% |
| 2020-Q10/3 |
LoseXRAY / S&P -31.19% / -19.60% |
LoseXRAY / S&P -0.49% / 3.47% |
LoseXRAY / S&P -107.89% / -14.75% |
| 2019-Q40/3 |
LoseXRAY / S&P 6.34% / 9.07% |
LoseXRAY / S&P 1.08% / 5.36% |
LoseXRAY / S&P -125.94% / 2.99% |
| 2019-Q30/3 |
LoseXRAY / S&P -8.48% / 1.70% |
LoseXRAY / S&P -1.01% / 5.02% |
LoseXRAY / S&P -109.54% / 0.21% |
| 2019-Q21/3 |
WinXRAY / S&P 17.87% / 4.30% |
LoseXRAY / S&P -3.78% / 6.64% |
LoseXRAY / S&P -106.32% / 8.65% |
| 2019-Q11/3 |
WinXRAY / S&P 33.51% / 13.65% |
LoseXRAY / S&P -1.80% / 8.12% |
LoseXRAY / S&P -30.21% / 14.29% |
| 2018-Q41/3 |
WinXRAY / S&P -1.17% / -13.52% |
LoseXRAY / S&P -0.19% / 9.05% |
LoseXRAY / S&P -33.77% / 18.23% |
| 2018-Q31/3 |
LoseXRAY / S&P -13.58% / 7.71% |
LoseXRAY / S&P 3.04% / 10.21% |
WinXRAY / S&P 109.12% / 19.06% |
| 2018-Q21/3 |
LoseXRAY / S&P -12.82% / 3.43% |
LoseXRAY / S&P 6.62% / 9.03% |
WinXRAY / S&P 105.19% / 14.46% |
| 2018-Q10/3 |
LoseXRAY / S&P -23.44% / -0.76% |
LoseXRAY / S&P 4.54% / 7.68% |
LoseXRAY / S&P -533.55% / 12.46% |
| 2017-Q41/3 |
WinXRAY / S&P 10.21% / 6.64% |
LoseXRAY / S&P 6.62% / 7.03% |
LoseXRAY / S&P -442.21% / 13.82% |
| 2017-Q31/3 |
LoseXRAY / S&P -7.62% / 4.48% |
WinXRAY / S&P 14.01% / 5.68% |
LoseXRAY / S&P -280.93% / 17.57% |
| 2017-Q22/3 |
WinXRAY / S&P 3.99% / 3.09% |
WinXRAY / S&P 23.42% / 4.83% |
LoseXRAY / S&P -262.15% / 17.74% |
| 2017-Q12/3 |
WinXRAY / S&P 8.31% / 6.07% |
WinXRAY / S&P 38.79% / 3.67% |
LoseXRAY / S&P -22.89% / 13.32% |
| 2016-Q42/3 |
LoseXRAY / S&P -2.73% / 3.82% |
WinXRAY / S&P 40.05% / 2.09% |
WinXRAY / S&P 13.07% / 7.05% |
| 2016-Q32/3 |
LoseXRAY / S&P -4.08% / 3.85% |
WinXRAY / S&P 25.63% / 0.20% |
WinXRAY / S&P -0.00% / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | XRAY total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -20.65% | 20.78% |
| Annualized return | -20.65% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | XRAY total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -80.00% | 83.14% |
| Annualized return | -27.52% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | XRAY total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -79.33% | 319.30% |
| Annualized return | -14.59% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Envista Holdings Corp (NVST) | United States | $3.866B | 46.70 |